Rheumatology & Therapy Issues Research Articles in August 2024 Edition
July 25, 2024
July 25, 2024
BASEL, Switzerland, July 25 -- Rheumatology and Therapy, a peer-reviewed journal that says it features the discovery, development and use of therapies for rheumatic diseases, published research articles on the following topics in its August 2024 edition (Vol. 11, Issue 4):
* Drug Persistence and Incidence of Active Tuberculosis of Tumor Necrosis Factor Alpha Inhibitors Versus Tocilizumab as the First-Line Biological Treatment in Patients with Rheumatoid Arthritis: A Nationwide Popul . . .
* Drug Persistence and Incidence of Active Tuberculosis of Tumor Necrosis Factor Alpha Inhibitors Versus Tocilizumab as the First-Line Biological Treatment in Patients with Rheumatoid Arthritis: A Nationwide Popul . . .